PROGRAM AT A GLANCE

DAY 1 FRIDAY, MAY 17, 2013

8:00 AM – 11:00 AM ISHIB ANNUAL CORPORATE PARTNERS ROUNDTABLE MEETING
(CLOSED SESSION)
8:00 AM – 11:00 AM DOC MEETING
(CLOSED SESSION)
11:00 AM – 12:00 PM AD BOARD (CLOSED SESSION)
1:00 PM – 4:00 PM REGISTRATION
1:00 PM – 4:30 PM BOARD OF TRUSTEES MEETING
(CLOSED SESSION)
5:00 PM – 8:00 PM
HYPERTENSION ACADEMY
 
CME: 3.00/CEU: .3
Upon completion of this session, participants should be able to:
  • Understand the epidemiology of and diagnostic criteria for resistant hypertension and its significance
  • Understand the epidemiology and diagnostic criteria for orthostatic hypotension
  • Understand the augmented risk of stroke and other forms of vascular disease in patients with primary aldosteronism
  • Understand the diagnostic criteria for uncontrolled hypertension, hypertensive urgencies, and hypertensive emergencies
  • Understand the rationale for utilization of diuretics in patients with ESRD
  • Introduction and OverviewModeratorElijah Saunders, MD
    Renal Artery Denervation for Severe Resistant Hypertension – Magic Bullet or Dead End?SpeakerJohn M. Flack, MD, MPH
    Diagnostic Strategies and Management Options for Orthostatic HypotensionSpeakerDomenic A. Sica, MD, PhD
    Hypertension Management in the Hospital SettingSpeakerErrol D. Crook, MD
    Primary Hyperaldosteronism: Diagnosis and Management of a Stealthy Etiology of Surgically Manageable (Sometimes) HypertensionSpeakerSusan P. Steigerwalt, MD
      Case Discussion: A Case of Severe Hypertension, Stroke, and Acute Kidney Failure in an Early Middle Aged WomanSpeakerJohn M. Flack, MD, MPH
      Question and AnswerModeratorElijah Saunders, MD
      ConclusionChairJohn M. Flack, MD, MPH
    DAY 1 SUMMARYConf Co-ChairJerome A. Robinson, MD
    TOTAL DAY 1 CME: 3/CEU: .3

    DAY 2 SATURDAY, MAY 18, 2013

    8:00 AM – 4:00 PM REGISTRATION Location: Office Equipment Room:
    7:30 AM – 8:30 AM
    OPENING CEREMONY/NEIL SHULMAN SYMPOSIUM
     
    CME: 1.00/CEU: .1
    KEYNOTE PRESENTATION:
    The Democratization of Health Care
    Keynote Speaker Gary A. Puckrein, PhD
      Gary A. Puckrein, PhD, is President and Chief Executive Officer of the National Minority Quality Forum. He also serves as Executive Director of the Alliance of Minority Medical Associations (a collaborative effort of the Asian and Pacific Physicians’ Association, the Association of American Indian Physicians, the Interamerican College of Physicians and Surgeons, and the National Medical Association). In 1989 Dr. Puckrein founded the Forum’s predecessor organization, the National Minority Health Month Foundation, to help communities and policy makers eliminate the disproportionate burden of premature death and preventable illness in special populations through the use of evidence-based, data-driven initiatives.

    Dr. Puckrein is responsible for congressional proclamations designating April as National Minority Health Month each year. Dr. Puckrein leads the Zip Code Analysis Project, which is building a comprehensive database that links vital statistics and other elements (including demographic, environmental, claims, prescription, laboratory, hospital, and clinic data) in a centralized warehouse, organized around zip codes. Dr. Puckrein has launched a series of atlases to measure and analyze health status in small geographic areas, evaluate the impact of specific interventions, and monitor changes in health outcomes. Dr. Puckrein has published successful magazines, American Visions and Minority Health Today. Dr. Puckrein was awarded his doctorate from Brown University, graduating Phi Beta Kappa.

    WelcomeConf Co-ChairJerome A. Robinson, MD
    Conference OverviewConf Co-ChairSusanne B. Nicholas, MD, PhD, MPH
    Introduction and Acknowledgement of ISHIB FoundersBoard of TrusteeDavid S. Kountz, MD, MBA
      KEYNOTE PRESENTATION:
    Healthcare Reform and Minority Cardiovascular Health
    Keynote Speaker 
      ConclusionConf Co-ChairJerome A. Robinson, MD
    8:30 AM – 10:00 PM
    EXHIBITS AND ABSTRACT POSTER SESSION
     
     
    10:00 – 11:40 AM
    ASH/ISHIB JOINT SESSION:
    The Jackson Heart Study Celebrates Ten (10) Years
     
    CME: 1.50/CEU: .15
    Upon completion of this session, participants should be able to:
  • Describe the antihypertensive medication use reported by the Jackson Heart Study cohort
  • Understand the profile of the Life Simple Seven and its impact on cardiovascular disease mortality in the African American South
  • Understand the variation in CVD risk by subclasses of HDL in the Jackson Heart Study (JHS)
  • To examine the associations between social and psychological factors and cardiovascular disease (CVD) among African Americans in the Jackson Heart Study
  • Opening RemarksSpeakerDomenic Sica, MD
    IntroductionChairHerman A. Taylor, Jr., MD, MPH
    Treatment of Hypertension Among African Americans: The JHSSpeakerEvelyn Walker, MD, MPH
    Social and Psychological Determinants of Cardiovascular HealthSpeakerMario Sims, PhD
      Life’s Simple 7 in the African American SouthSpeakerAdolfo Correa MD, PhD, MBA
      HDL Subfractions and CVD Morbidity and MortalitySpeakerMichael Griswold, PhD
      Questions and AnswersChairHerman A. Taylor, Jr., MD, MPH
      ConclusionChairHerman A. Taylor, Jr., MD, MPH
    11:30 AM – 2:00 PM
    EXHIBITS AND ABSTRACT POSTER SESSION
     
    Location:
    11:45 AM – 12:30 PM
    PRODUCT THEATER I:
    The Clinical Case for Edarbyclor: Combination Therapy of Edarbi and Chlorthalidone in Treating Hypertension
     
    SUPPORTED BY: Takeda Pharmaceuticals U.S.A., Inc.
     SpeakerDavid S. Kountz, MD, MBA
    1:00 PM – 1:45 PM
    PRODUCT THEATER II:
    AZOR® and TRIBENZOR ®: The Power of Fixed-Dose Combination Therapy
     
    SUPPORTED BY: Daiichi Sankyo, Inc.
       SpeakerKenneth A. Jamerson, MD
    2:00 PM – 3:30 PM
    PLENARY SESSION I:
    Diabetes, Hypertension, and African Americans
     
    CME: 1.50/CEU: .15
    Upon completion of this session, participants should be able to:
  • Understand the common etiologic factor in Diabetes and Hypertension
  • Review the challenges of diabetes prevalence, complications and management in African Americans
  • Discuss the ethnic/racial phenotypes of Metabolic Syndrome
  • IntroductionChairKwame Osei, MD
    New Guidelines in Diabetes Management: Implications for African AmericansSpeakerSamuel Dagogo-Jack, MD
    Diabetes and Hypertension: Selection of Appropriate Therapies SpeakerJames W. Reed, MD
    Metabolic Syndrome Paradox in African Americans: New Insights to DyslipidemiaSpeakerTrudy Gaillard, PhD, RN, CDE
      Question and AnswersSpeakerKwame Osei, MD
      ConclusionConf Co-ChairKwame Osei, MD
    4:00 PM – 5:00 PM
    WORKSHOP A: Mechanical Interventions to Treat Hypertension
     
    CME: 1.00/CEU: .10
    Upon completion of this session, participants should be able to:
  • Understand pathophysiology of the carotid baroreceptor response
  • IntroductionChairGerman T. Hernandez, MD
    Renal Artery Revasculation Myth, Fantasy for RealityPresenterJerome A. Robinson, MD
    Carotid Baroreceptor StimulationSpeakerAngela L. Brown, MD
      Question and AnswersChairGerman T. Hernandez, MD
      ConclusionChairGerman T. Hernandez, MD
    DAY 2 SUMMARYConf Co-ChairSusanne B. Nicholas, MD, PhD, MPH
    5:00 PM – 6:30 PM
    EXHIBIT AND ABSTRACT POSTER SESSION
     
    Location:
    6:30 PM – 7:00 PM
    AWARDs CEREMONY
     
     
    7:00 PM – 8:00 PM
    PRESIDENT’ S RECOGNITION RECEPTION
     
    Supported by: Takeda Pharmaceuticals USA, Inc.
    TOTAL DAY 2 CME: 5.0/CEU .50

    DAY 3 SUNDAY, MAY 19, 2013

    7:00 AM – 1:00 PM REGISTRATION Location:
    Office Equipment Room:
    9:00 AM – 10:30 AM
    PLENARY SESSION II:
    Community Interventions That Work!
     
    CME: 1.50/CEU: .15
    Upon completion of this session, participants should be able to:
  • Identify the effects of diet and nutrition on hypertension
  • Describe innovation community interventions
  • Highlight how community interventions can improve health outcomes
  • Connect community interventions to the goals of the Affordable Care Act
  • IntroductionChairKeith C. Norris, MD
    Hypertension: the Mismatch of Your Genes and LifestyleSpeakerZhaoping Li, MD, PhD
    Sisters in Motion: A Faith-Based Approach to Enhance Physical ActivitySpeakerObidiugwu Kenrik Duru, MD, MSHS
      A Tale of Two Sites: Barbershop and Church-based Lifestyle Interventions to Improve Hypertension in Black MenSpeakerJoseph E. Ravenell, MD, MS
      Question and AnswersModeratorKeith C. Norris, MD
      ConclusionChairKeith C. Norris, MD
    10:00 AM – 12:00 PM
    EXHIBIT AND ABSTRACT POSTER SESSION
     
    Location:
    11:00 AM – 12:15 PM
    W. DALLAS HALL BLUE RIBBON SESSION
     
    CME: 1.00/CEU: .10
    Location:
    Upon completion of this session, participants should be able to:
  • Describe the relationship between acculturation and the prevalence of risk factors for heart disease among Jamaican Immigrants in the US
  • IntroductionChairAngela L Brown, MD
      AN EXAMINATION OF ACCULTURATION AND RISK FACTORS FOR HEART DISEASE AMONG JAMAICAN IMMIGRANTS Speaker Carol Oladele, PhD
      PREDICTING CARDIOVASCULAR RISK: SYSTOLIC, DIASTOLIC, MEAN OR PULSE PRESSURE?Speaker Hakeem Ayinde, MD
      BLUE RIBBON PRESENTATION #1Presenters TBA
      BLUE RIBBON PRESENTATION #2Presenters TBA
      BLUE RIBBON PRESENTATION #3Presenters TBA
      Question and AnswersModeratorAngela L Brown, MD
      ConclusionChair Angela L Brown, MD
      DAY 3 SUMMARY/MEETING CLOSES  David S. Kountz, MD, MBA
    TOTAL DAY 1 CME: 3/CEU: .3
    TOTAL DAY 2 CME: 3.5/CEU .35
    TOTAL DAY 3 CME: 2.5/CEU .25
    TOTAL CME: 9.0/CEU .90